Form 4 for IDXX Idexx Laboratories
Accepted 2021-10-13 00:00:00 ET · period of report 2021-10-11 · accession 0001567619-21-018262 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-13 | 2021-10-11 | IDXX | Claflin Bruce L. | Dir | M - OptEx | $160.28 | +1,921 | 1,921 | New | +$307.9K |
| D | 2021-10-13 | 2021-10-11 | IDXX | Claflin Bruce L. | Dir | M - OptEx | — | -1,921 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-11 | M | A | 1,921 | $160.28 | 1,921 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2021-10-11 | M | D | 1,921 | — | 0 | D | $160.28 · — to 2027-05-02 | 1,921 Common Stock | (F2) Not applicable. (F1) Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2018. |